200 studies found for:    rsv
Show Display Options
Rank Status Study
1 Active, not recruiting RSV F Vaccine Maternal Immunization Study in Healthy Third-trimester Pregnant Women.
Condition: Respiratory Syncytial Virus Infections
Interventions: Drug: Saline Placebo (0.5mL injection);   Drug: RSV F vaccine (0.5mL injection)
2 Active, not recruiting Safety, Reactogenicity and Immunogenicity Study of Different Formulations of GlaxoSmithKline (GSK) Biologicals' Investigational RSV Vaccine (GSK3003891A), in Healthy Women
Condition: Respiratory Synctial Virus Infections
Interventions: Biological: RSV vaccine GSK3003895A (formulation 1);   Biological: RSV vaccine GSK3003898A (formulation 2);   Biological: RSV vaccine GSK3003899A (formulation 3);   Biological: Boostrix
3 Active, not recruiting A Study to Evaluate the Efficacy of an RSV F Vaccine in Older Adults
Condition: Respiratory Syncytial Virus (RSV)
Interventions: Biological: RSV-F Vaccine;   Biological: Phosphate Buffer Placebo
4 Active, not recruiting RSV001 - A New Vaccine to Prevent Severe Viral Chest Infections.
Condition: Respiratory Syncytial Virus Infections
Interventions: Biological: PanAd3-RSV given intra-nasally (high dose);   Biological: MVA-RSV given by intra-muscular injection (high dose);   Biological: PanAd3-RSV given by intra-muscular injection (high dose);   Biological: PanAd3-RSV given intranasally (low dose);   Biological: MVA-RSV given by intra-muscular injection (low dose);   Biological: PanAd3-RSV given by intra-muscular injection (low dose)
5 Recruiting A Study to Evaluate the Safety, Tolerability and Immunogenicity of Ad35.RSV.FA2 Regimens Boosted With Ad26.RSV.FA2 in Healthy Adult Participants
Condition: Healthy Participants
Interventions: Biological: Ad35.RSV.FA2;   Biological: Ad26.RSV.FA2;   Drug: Placebo
6 Completed Phase 2b Study of ALN-RSV01 in Lung Transplant Patients Infected With Respiratory Syncytial Virus (RSV)
Condition: Respiratory Syncytial Virus Infections
Interventions: Drug: ALN-RSV01;   Drug: Normal Saline
7 Active, not recruiting Placebo- Controlled Study to Evaluate the Safety and Immunogenicity of the RSV-F Vaccine in Elderly Adults
Condition: Respiratory Syncytial Virus (RSV)
Interventions: Biological: RSV-F Vaccine;   Biological: Saline Placebo
8 Recruiting A Study to Determine the Safety and Efficacy of the RSV F Vaccine to Protect Infants Via Maternal Immunization
Condition: Respiratory Syncytial Virus Infections
Interventions: Biological: RSV F vaccine with adjuvant;   Biological: Formulation buffer
9 Recruiting A Study to Evaluate the Safety and Reactogenicity of DPX-RSV(A), a Respiratory Syncytial Virus Vaccine
Condition: Respiratory Syncytial Virus
Interventions: Biological: DPX-RSV(A);   Biological: RSV(A)-Alum;   Other: Placebo
10 Completed Phase 2 Study of ALN-RSV01 in Lung Transplant Patients Infected With Respiratory Syncytial Virus (RSV)
Condition: Respiratory Syncytial Virus Infections
Interventions: Drug: ALN-RSV01;   Drug: normal saline
11 Recruiting A Study to Evaluate the Safety, Tolerability and Immunogenicity of Ad26.RSV.FA2 Followed by Ad35.RSV.FA2 in Healthy Adult Volunteers
Conditions: Respiratory Syncytial Viruses;   Respiratory Tract Infections
Interventions: Biological: Ad26.RSV.FA2;   Biological: Ad35.RSV.FA2;   Drug: Placebo
12 Active, not recruiting Trial to Evaluate the Safety, Tolerability and Immunogenicity of the Recombinant MVA BN® RSV Vaccine
Condition: Respiratory Syncytial Virus Infections
Interventions: Biological: MVA BN RSV;   Other: Placebo
13 Recruiting To Evaluate the Safety and Ability of the Medicine to Induce Antibodies Against the Respiratory Syncytial Virus in Healthy Adults
Condition: Respiratory Syncytial Virus (RSV)
Interventions: Biological: RSV F subunit vaccine-Low dosage; no adjuvant;   Biological: RSV F subunit vaccine-Medium dosage; no adjuvant;   Biological: RSV F subunit vaccine-High dosage; no adjuvant;   Biological: RSV F subunit vaccine-Low dosage; with aluminum hydroxide;   Biological: RSV F subunit vaccine-Medium dosage; with aluminum hydroxide;   Biological: RSV F subunit vaccine-High dosage; with aluminum hydroxide;   Biological: RSV F subunit vaccine-Low dosage; with MF59;   Biological: RSV F subunit vaccine-Medium dosage; with MF59;   Biological: RSV F subunit vaccine-High dosage; with MF59;   Biological: Placebo-Sterile Saline
14 Recruiting Evaluating the Safety and Immune Response to a Single Dose of a Respiratory Syncytial Virus (RSV) Vaccine in Infants and Children
Condition: Respiratory Syncytial Virus Infections
Interventions: Biological: RSV ΔNS2 Δ1313 I1314L Vaccine;   Biological: Placebo (1x Leibovitz L-15 medium)
15 Active, not recruiting Safety and Immunogenicity of the RSV-F Vaccine in Older Adults Previously Treated With the Same Vaccine or Placebo in the Prior Year.
Condition: Respiratory Syncytial Virus (RSV)
Interventions: Biological: RSV-F Vaccine;   Biological: Phosphate Buffer Placebo
16 Completed RSV-F Vaccine Dose Ranging Study in Young Women
Condition: Respiratory Syncytial Virus (RSV)
Interventions: Biological: Low dose RSV-F Vaccine with Adjuvant;   Biological: Low dose RSV-F Vaccine without Adjuvant;   Biological: High dose RSV-F Vaccine with Adjuvant;   Biological: High dose RSV-F Vaccine without Adjuvant;   Biological: Low dose RSV-F Vaccine with Adjuvant [Bedside Mixing];   Biological: Placebo
17 Completed Azithromycin to Prevent Wheezing Following Severe Respiratory Syncytial Virus (RSV) Bronchiolitis
Condition: RSV Bronchiolitis
Intervention: Drug: Azithromycin
18 Completed Evaluating the Safety and Immune Response to a Single Dose of a Respiratory Syncytial Virus (RSV) Vaccine in RSV-Seronegative Infants and Children
Condition: Respiratory Syncytial Virus Infections
Interventions: Biological: RSV cps2 Vaccine;   Biological: Placebo Vaccine
19 Active, not recruiting Evaluating the Safety and Immune Response to a Single Dose of a Respiratory Syncytial Virus (RSV) Vaccine in RSV-Seronegative Infants and Children
Condition: Respiratory Syncytial Virus Infections
Interventions: Biological: RSV cps2 Vaccine;   Biological: Placebo Vaccine
20 Completed Exhaled Nitric Oxide in Respiratory Syncytial Virus (RSV) Bronchiolitis: a Pilot Study
Conditions: RSV Infection;   Bronchiolitis
Intervention: Other: Collection of exhaled breath

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years